Women’s Health Update

Sunday, June 18; 8:30 AM – 10:30 AM • 2 hours CPE

0142-0000-17-035-L04-P | 0142-0000-17-035-L04-T

Instructors
Kendra Manigault, PharmD, BCPS, BCACP, CDE; Clinical Assistant Professor, Mercer University College of Pharmacy

Kalen Manasco, PharmD, BCPS; Clinical Professor, University of Florida College of Pharmacy/UF Health Shands

Description
Part 1, led by Kendra Manigault, looks at the authority pharmacists in other states have to provide hormonal contraceptives without a prescription. Kendra will offer an overview of hormonal contraception and important factors to consider when selecting therapy for patients. She will also discuss common adverse reactions and how to identify patients who are ineligible to receive hormonal contraceptive pharmacotherapy.

Part 2, led by Kalen Mansco, looks at what pharmacists need to know about medication use during pregnancy and lactation. Kalen will focus on a review of drug transfer across the placenta and into breast milk, the new FDA fetal risk summary categories for medications, and discuss resources available for pharmacists to make recommendations for women who are pregnant and breastfeeding.

Learning objectives
After completing this session, learners will be able to: